Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Myelination of the nervous system: mechanisms and functions.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Optic nerve disease and axon pathophysiology.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Age-dependent effects on the treatment response of natalizumab in MS patients.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Multiple sclerosis: summary of NICE guidance.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Management of multiple sclerosis: An overview.
Long-Term Results Underscore Value of Early MS Treatment
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program.
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.

Pages